UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Heartwood Wealth Advisors LLC

Posted by on Jun 27th, 2023

Heartwood Wealth Advisors LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 14.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 685 shares of the healthcare conglomerate’s stock after acquiring an additional 87 shares during the period. Heartwood Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $324,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in UNH. Vanguard Group Inc. raised its position in UnitedHealth Group by 1.0% in the third quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock valued at $41,903,103,000 after purchasing an additional 851,994 shares during the period. Geode Capital Management LLC raised its position in UnitedHealth Group by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 16,858,436 shares of the healthcare conglomerate’s stock valued at $8,921,651,000 after purchasing an additional 247,997 shares during the period. Morgan Stanley raised its position in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after purchasing an additional 1,893,192 shares during the period. Moneta Group Investment Advisors LLC raised its position in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Finally, Alliancebernstein L.P. raised its position in UnitedHealth Group by 4.1% in the fourth quarter. Alliancebernstein L.P. now owns 10,499,294 shares of the healthcare conglomerate’s stock valued at $5,566,516,000 after purchasing an additional 414,032 shares during the period. 92.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. SVB Securities dropped their price objective on UnitedHealth Group from $625.00 to $560.00 in a research note on Wednesday, June 14th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a research note on Monday, April 17th. Stephens reaffirmed an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Cantor Fitzgerald started coverage on UnitedHealth Group in a research note on Thursday, April 20th. They set an “overweight” rating and a $591.00 target price for the company. Finally, TD Cowen lowered their target price on UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a research note on Monday, April 17th. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $592.68.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the sale, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the transaction, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The disclosure for this sale can be found here. Insiders sold a total of 8,852 shares of company stock valued at $4,313,962 in the last ninety days. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 0.5 %

NYSE:UNH opened at $479.20 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a market cap of $446.15 billion, a P/E ratio of 21.91, a P/E/G ratio of 1.39 and a beta of 0.68. The stock has a 50-day simple moving average of $484.66 and a 200-day simple moving average of $491.47.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business had revenue of $91.93 billion during the quarter, compared to the consensus estimate of $89.77 billion. During the same period in the previous year, the business earned $5.49 EPS. The business’s quarterly revenue was up 14.7% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be issued a $1.88 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend is Thursday, June 15th. UnitedHealth Group’s payout ratio is presently 34.39%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.